ATE336577T1 - Protein, welches durch einen cystinknoten charakterisiert ist und verfahren zu dessen herstellung - Google Patents

Protein, welches durch einen cystinknoten charakterisiert ist und verfahren zu dessen herstellung

Info

Publication number
ATE336577T1
ATE336577T1 AT99906984T AT99906984T ATE336577T1 AT E336577 T1 ATE336577 T1 AT E336577T1 AT 99906984 T AT99906984 T AT 99906984T AT 99906984 T AT99906984 T AT 99906984T AT E336577 T1 ATE336577 T1 AT E336577T1
Authority
AT
Austria
Prior art keywords
polypeptides
cystin
knot
production
protein characterized
Prior art date
Application number
AT99906984T
Other languages
English (en)
Inventor
Paul O Sheppard
Si Lok
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE336577T1 publication Critical patent/ATE336577T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Environmental Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99906984T 1998-02-13 1999-02-12 Protein, welches durch einen cystinknoten charakterisiert ist und verfahren zu dessen herstellung ATE336577T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2357098A 1998-02-13 1998-02-13

Publications (1)

Publication Number Publication Date
ATE336577T1 true ATE336577T1 (de) 2006-09-15

Family

ID=21815915

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99906984T ATE336577T1 (de) 1998-02-13 1999-02-12 Protein, welches durch einen cystinknoten charakterisiert ist und verfahren zu dessen herstellung

Country Status (7)

Country Link
EP (1) EP1053324B1 (de)
JP (1) JP2002503467A (de)
AT (1) ATE336577T1 (de)
AU (1) AU2676399A (de)
CA (1) CA2320391A1 (de)
DE (1) DE69932804T2 (de)
WO (1) WO1999041377A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078964A1 (en) * 1999-06-17 2000-12-28 Amgen Inc. Glycoprotein hormone family member
WO2001044475A1 (fr) * 1999-12-17 2001-06-21 Takeda Chemical Industries, Ltd. Nouveau polypeptide et son adn
US7514239B2 (en) 2000-03-28 2009-04-07 Amgen Inc. Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
WO2001085783A2 (en) * 2000-05-08 2001-11-15 Serono, Inc. Nucleic acids encoding polypeptides related to the alpha subunit of the glycoprotein hormone family and methods of use thereof
EP1330469A2 (de) * 2000-08-11 2003-07-30 Applied Research Systems ARS Holding N.V. Glycoproteine und deren verwendungen
CA2454181A1 (en) * 2001-07-13 2003-01-23 Zymogenetics, Inc. Use of corticotroph-derived glycoprotein hormone to induce lipolysis
CA2555908A1 (en) * 2004-03-05 2005-09-22 Zymogenetics, Inc. Use of corticotroph-derived glycoprotein hormone to treat liver steatosis

Also Published As

Publication number Publication date
EP1053324A1 (de) 2000-11-22
WO1999041377A1 (en) 1999-08-19
JP2002503467A (ja) 2002-02-05
DE69932804T2 (de) 2007-08-23
EP1053324B1 (de) 2006-08-16
AU2676399A (en) 1999-08-30
CA2320391A1 (en) 1999-08-19
DE69932804D1 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
Atoda et al. The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Homology with asialoglycoprotein receptors, proteoglycan core protein, tetranectin, and lymphocyte Fc epsilon receptor for immunoglobulin E
DE69535375D1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
HU903740D0 (en) Process for the production of new proteins
EP1717315A3 (de) Osteoprotegerin bindende Proteine und Rezeptoren
DE3486154D1 (de) Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung.
UA40621C2 (uk) Моноклональне антитіло, гібридомна клітинна лінія, поліпептид (варіанти), фрагмент днк (варіанти), фармацевтична композиція, спосіб одержання моноклонального антитіла
WO1995021919A3 (en) Protein having tpo activity
DE68916932D1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
EP1096013A3 (de) Corynebacterium poxB-Gen codierende Nukleotidsequenzen, und die Verwendung zur Herstellung von L-Lysin
HUT63652A (en) Process for producing cd44 surface protein variants, dna sequences encoding them and antibodies against them, as well as their application in diagnosis and therapy
Schuppan et al. Covalent Structure of Mouse Type‐IV Collagen: Isolation, Order and Partial Amino‐Acid Sequence of Cyanogen‐Bromide and Tryptic Peptides of Pepsin Fragment P1 from the αl (IV) Chain
DE69934995D1 (de) Für den menschlichen wachstums-differenzierungsfaktor kodierende sequenz und polypeptid, welches durch solche dna-sequenz kodiert wird und verfahren zur herstellung
CA2130900A1 (en) Therapeutic domains of von willebrand factor
ATE336577T1 (de) Protein, welches durch einen cystinknoten charakterisiert ist und verfahren zu dessen herstellung
ATE109156T1 (de) Elastase-inhibierungspolypeptide und verfahren zur herstellung durch genetische rekombination.
Mann et al. The primary structure of a triple-helical domain of collagen type VIII from bovine Descemet's membrane
DE69128416T2 (de) Fibronektin bindendes Peptid
ATE154362T1 (de) Verfahren zur herstellung von pai-2
HUT76835A (en) Process for producing pharmaceuticals for treatment of anxiety and panic and gabapentin binding protein
ATE403673T1 (de) Faktor-2 homolog zum fibroblasten-wachstumsfaktor und verfahren zu seiner anwendung
AU7649098A (en) Syndecan interacting proteins and the use thereof
WO2005019407A3 (en) Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases
DE69731312D1 (de) Peptide spezifisch für antikörper gegen peptidconcensussequenzen aus der cs4-cfa/iprpteinfamilie
WO2003044159A9 (en) Zinc finger proteins, polynucleotides encoding same and antibodies thereto
TERMINE LARRY W. FISHER*, WOLFGANG LINDNER#, MARIAN F. YOUNG

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1053324

Country of ref document: EP

REN Ceased due to non-payment of the annual fee